Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
JAMA Health Forum|June 23, 2023
Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology DrugsJessica Chang, Pinar Karaca-Mandic, Sayeh Nikpay, et al.Medical Care|June 12, 2012
The effectiveness of a health promotion program after 3 years: evidence from the University of MinnesotaJohn A Nyman, Jean M Abraham, Molly Moore Jeffery, et al.Evidence Report/Technology Assessment|January 16, 2014
Closing the quality gap: revisiting the state of the science (vol. 7: quality improvement measurement of outcomes for people with disabilities)Mary Butler, Robert L Kane, Sheryl Larson, et al.The American Journal of Managed Care|October 17, 2022
Changes in opioid marketing practices after release of the CDC guidelinesAdeniyi T Togun, Pinar Karaca-Mandic, Rebecca Wurtz, et al.International Journal of Clinical Pharmacy|December 2, 2021
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factorsAdeniyi T Togun, Pinar Karaca Mandic, Rebecca Wurtz, et al.Health Affairs (Project Hope)|November 5, 2019
Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare AdvantagePinar Karaca-Mandic, Jessica Chang, Ronald Go, et al.BMC Medical Research Methodology|August 28, 2024
Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional studyGuneet S Janda, Molly Moore Jeffery, Reshma Ramachandran, et al.Journal of Occupational and Environmental Medicine|October 30, 2013
The 3-year disease management effect: understanding the positive return on investmentJohn A Nyman, Molly Moore Jeffery, Jean M Abraham, et al.American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 21, 2013
Emergency department utilization as a measure of physician performanceBryan Dowd, Medha Karmarker, Tami Swenson, et al.The American Journal of Managed Care|May 25, 2023
Provider barriers in uptake of biosimilars: case study on filgrastimJessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.Pageof 4